Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making.

Researchers conducted a comprehensive review of studies examining treatments for attention deficit/hyperactivity disorder (ADHD) across all ages. They analyzed 221 different treatment approaches including medications and non-medication therapies like acupuncture, cognitive behavioral therapy, and mindfulness.

For children and adolescents, several medications showed strong evidence for reducing ADHD symptoms in the short term (up to 12 weeks). These included methylphenidate, amphetamines, atomoxetine, alpha-2 agonists, and viloxazine. However, some medications had side effects that led people to stop treatment. For adults, methylphenidate, amphetamines, atomoxetine, and cognitive behavioral therapy showed moderate effectiveness.

Regarding acupuncture, the study found that it showed large improvements in ADHD symptoms for children and adolescents. However, the researchers rated the quality of evidence as low, meaning more rigorous research is needed before we can be confident about acupuncture's effectiveness for ADHD. The study also noted that mindfulness showed promise for adults with ADHD, though again with lower certainty evidence.

An important limitation was that no treatment had high-quality, long-term evidence (beyond one year). Most studies only looked at short-term effects.

What this means: While acupuncture may help some children and teens with ADHD symptoms, the current evidence isn't strong enough to make definitive recommendations. It could be considered as part of a comprehensive treatment plan, especially for families seeking non-medication options or additional support alongside other treatments. If you're considering acupuncture for ADHD, find a licensed acupuncturist with experience treating children or adults with attention disorders.

This umbrella review analyzed 221 unique intervention-outcome combinations from 47 meta-analytic reports of randomized controlled trials examining ADHD treatments across the lifespan. Methodological quality was assessed using AMSTAR-2, with evidence certainty evaluated via an algorithmic GRADE framework.

For pediatric populations, stimulant medications (methylphenidate, amphetamines) and non-stimulants (atomoxetine, alpha-2 agonists, viloxazine) demonstrated medium to large effect sizes (SMD >0.75) with moderate to high certainty evidence for short-term symptom reduction. Adult populations showed similar efficacy patterns for methylphenidate, amphetamines, atomoxetine, and cognitive behavioral therapy.

Acupuncture showed large effect sizes for ADHD symptoms in children and adolescents, but with low certainty evidence, limiting clinical confidence. Mindfulness demonstrated promise in adults, also with low certainty. Critically, no intervention demonstrated high-certainty long-term evidence beyond 12 weeks.

Clinical takeaway: While acupuncture may serve as an adjunctive treatment option for pediatric ADHD, current evidence quality precludes it as a first-line recommendation. Practitioners should counsel patients about limited evidence certainty when discussing non-pharmacological alternatives.